These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19864389)

  • 1. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs.
    Chen Z; Wang W; Zhou H; Suguitan AL; Shambaugh C; Kim L; Zhao J; Kemble G; Jin H
    J Virol; 2010 Jan; 84(1):44-51. PubMed ID: 19864389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs.
    Wang W; Lu J; Cotter CR; Wen K; Jin H; Chen Z
    J Virol; 2013 Apr; 87(8):4642-9. PubMed ID: 23408613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
    Lu B; Zhou H; Ye D; Kemble G; Jin H
    J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
    Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
    J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
    Zhang W; Xue T; Wu X; Zhang P; Zhao G; Peng D; Hu S; Wang X; Liu X; Liu W; Liu X
    Vaccine; 2011 Oct; 29(45):8032-41. PubMed ID: 21864614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic engineering of live attenuated influenza viruses.
    Jin H; Chen Z; Liu J; Kemble G
    Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity.
    Barman S; Franks J; Turner JC; Yoon SW; Webster RG; Webby RJ
    Vaccine; 2015 Jun; 33(28):3186-92. PubMed ID: 25999284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds.
    Ramanunninair M; Le J; Onodera S; Fulvini AA; Pokorny BA; Silverman J; Devis R; Arroyo JM; He Y; Boyne A; Bera J; Halpin R; Hine E; Spiro DJ; Bucher D
    PLoS One; 2013; 8(6):e65955. PubMed ID: 23776579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of the pandemic (H1N1) 2009 virus and its reassortant with an H3N2 swine influenza virus from healthy weaning pigs in Thailand in 2011.
    Hiromoto Y; Parchariyanon S; Ketusing N; Netrabukkana P; Hayashi T; Kobayashi T; Takemae N; Saito T
    Virus Res; 2012 Oct; 169(1):175-81. PubMed ID: 22906589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.
    Kodihalli S; Justewicz DM; Gubareva LV; Webster RG
    J Virol; 1995 Aug; 69(8):4888-97. PubMed ID: 7609057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
    Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
    Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composition of hemagglutinin and neuraminidase affects the antigen yield of influenza A(H1N1)pdm09 candidate vaccine viruses.
    Shirakura M; Kawaguchi A; Tashiro M; Nobusawa E
    Jpn J Infect Dis; 2013; 66(1):65-8. PubMed ID: 23429089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.
    Harvey R; Guilfoyle KA; Roseby S; Robertson JS; Engelhardt OG
    J Virol; 2011 Jun; 85(12):6086-90. PubMed ID: 21490098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments.
    Gomila RC; Suphaphiphat P; Judge C; Spencer T; Ferrari A; Wen Y; Palladino G; Dormitzer PR; Mason PW
    Vaccine; 2013 Oct; 31(42):4736-43. PubMed ID: 23973324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
    McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
    Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants.
    Rudneva IA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Varich NL; Ilyushina NA; Gambaryan AS; Krylov PS; Kaverin NV
    Arch Virol; 2007; 152(6):1139-45. PubMed ID: 17294090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets.
    Yang P; Duan Y; Wang C; Xing L; Gao X; Tang C; Luo D; Zhao Z; Jia W; Peng D; Liu X; Wang X
    Vaccine; 2011 Jan; 29(4):698-705. PubMed ID: 21111782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-yield reassortant virus containing hemagglutinin and neuraminidase genes of pandemic influenza A/Moscowl/01/2009 (H1N1) virus].
    Ignat'eva AV; Rudneva IA; Timofeeva TA; Shilov AA; Zaberezhnyĭ AD; Aliper TI; Kaverin NV; L'vov DK
    Vopr Virusol; 2011; 56(4):9-14. PubMed ID: 21899062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.